Ticker APLT – Applied Therapeutics – sales, description, marketcap – Tickerday.com

APLT

Applied Therapeutics

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 656.01M; Volume: 227.27K; AvgVol 3m: 217.46K; Beta: –;

Cost estimate:

P/E: –; EPS: -3.77; EPS growth quarter/prev quarter: -110.20%;

EPS growth this year: -266.10%; EPS growth past 5 years: ;

EPS ttm: -4.44;

P/S: ; P/B: 3.77; P/Cashflow: 3.60; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -68.40%; ROE – return on equity: -78.70%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 4.50%; Insider Transactions:-27.67%;

Institutional Ownership: 69.00%; Institutional Transactions: 16.45%;

Data update: 07/10/2020.